Navigation Links
ZIOPHARM Presents ZIO-201 Lymphoma Data at ISH

ealizing the broader therapeutic potential for this novel agent."

About ZIO-201

ZIO-201, the active moiety of IFOS, is a bi-functional alkylator that causes irreparable inter-strand DNA cross-linking resulting in cell death. ZIO-201 is equal to or more active than IFOS in diverse cancer models. Unlike IFOS which is a pro-drug, ZIO-201 is directly active against cancer cells. Also, unlike IFOS, ZIO-201 is not metabolized to acrolein or chloracetaldehyde which cause bladder or central nervous system toxicities. ZIO-201 continues in a phase I trial in diverse cancers exploring maximum tolerated dose at alternate schedules. A phase II trial in advanced sarcoma continues to enroll patients. Trials in lymphoma and pediatric cancers are in the advanced planning stage. An oral form of ZIO-201 is in advanced preclinical development.

About ZIOPHARM Oncology, Inc.

ZIOPHARM Oncology, Inc. is a biopharmaceutical company engaged in the development and commercialization of a diverse, risk-sensitive portfolio of in-licensed cancer drugs to address unmet medical needs. The Company applies new insights from molecular and cancer biology to understand the efficacy and safety limitations of approved and developmental cancer therapies and identifies proprietary and related molecules for better patient treatment. For more information, visit www.ziopharm.com.

Forward-Looking Safe Harbor Statement:

This press release contains forward-looking statements for ZIOPHARM Oncology, Inc. that involve risks and uncertainties that could cause the Company's actual results to differ materially from the anticipated results and expectations expressed in these forward-looking statements. These statements are based on current expectations, forecasts and assumptions that are subject to risks and uncertainties, which could cause actual outcomes and results to differ materially from these statements. Among other things, there can be no assurance that any of the Compan
'"/>




Page: 1 2 3

Related medicine technology :

1. ZIOPHARM to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
2. ZIOPHARM Presents Data Highlighting Oral ZIO-101 at AACR
3. ZIOPHARM Presents Data on Orally Active ZIO-201 at AACR
4. ZIOPHARM Presents Unique Mechanism Data for Indibulin at AACR
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
7. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
8. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
9. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
10. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
11. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: ZIOPHARM Presents ZIO Lymphoma Data ISH
(Date:5/4/2015)... Unchained Labs, a refreshingly new biologic tools ... conference and launches the UNit — the first and ... Essential Protein Engineering Summit takes place in ... UNit lets drug discovery researchers look at more protein ... 7 applications, 144 sample a day throughput and 9 microliter sample ...
(Date:5/4/2015)... May 4, 2015 Intarcia Therapeutics, ... Michael Williams into the newly created role ... a senior pharmaceutical executive with world-class experience – ... and distinguished service at industry leaders such as ... a broad range of therapeutic areas, including: cardiovascular, ...
(Date:5/4/2015)... N.J. , May 4, 2015 ... immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber ... multiple countries worldwide, will report Q1 2015 financial ... 11, 2015.  CytoSorbents, management will ... that will recount both operational and financial progress ...
Breaking Medicine Technology:Unchained Labs Lets the UNit Loose 2Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 2Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 3Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 4CytoSorbents to Report Q1 2015 Operating and Financial Results 2CytoSorbents to Report Q1 2015 Operating and Financial Results 3
... Inhibitex, Inc. (Nasdaq: INHX ) today announced that ... its common stock, at a purchase price of $4.10 per ... proceeds to Inhibitex from the sale of the shares, after ... to be approximately $44 million.  Inhibitex has granted the underwriters ...
... Robinson, Ph.D., Chief Scientific Officer at GeoVax Labs, Inc. (OTCQB/OTCBB: ... Company,s therapeutic and preventative HIV vaccines at the 2011 World ... in Washington DC on Thursday, April 14.  Dr. Robinson,s invited ... cover the topic of recombinant viruses as vaccines. The talk ...
Cached Medicine Technology:Inhibitex Prices $47 Million Public Offering 2Inhibitex Prices $47 Million Public Offering 3GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress 2GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress 3
(Date:5/4/2015)... Peacock Alley knows we all ... “My mother was the most beautiful woman I ever saw.” ... feminine prints and textures to remind her just ... the Eloise Robe to get you there. The beautiful Monet-inspired ... and tapered waist. It is available in small/medium or large/extra ...
(Date:5/4/2015)... 04, 2015 Today, Cireson reveals the ... Cireson Platform to strengthen core service & asset ... choice to consume Microsoft System Center and Cireson via ... , Company transitioning from a direct sales ... Continuous innovation with expanding new solutions for password reset ...
(Date:5/3/2015)... May 03, 2015 AvePoint, ... across platforms and devices, today announced it is ... Privacy Professionals (IAPP) Asia Privacy Forum, taking place ... Throughout the event, AvePoint will showcase its compliance, ... cloud platforms. , Visit AvePoint for New Solutions ...
(Date:5/3/2015)... Lake Orion, Clarkston, Metamora, Michigan (PRWEB) May 03, 2015 ... the 2,000 ‘Like’ mark on their Facebook page. ... educate the patients on the many services the Practice ... well as current events. , Women’s Excellence has a ... Twitter, Google +, Pinterest, Instagram and You Tube. ...
(Date:5/3/2015)... (PRWEB) May 03, 2015 Leading international ... announced it will be awarding the 2015 Harris Wofford ... and Selemawit Ghebrendrias, are the deserving recipients of the ... global service, Harris Llewellyn Wofford. The two recipients were ... passion for global health. , CFHI is one ...
Breaking Medicine News(10 mins):Health News:Feminine Classics for Mother's Day Gifts from Peacock Alley 2Health News:Cireson Unveils New Microsoft Cloud & System Center Strategy 2Health News:Cireson Unveils New Microsoft Cloud & System Center Strategy 3Health News:Cireson Unveils New Microsoft Cloud & System Center Strategy 4Health News:AvePoint Showcases Compliance and Data Privacy Solutions as Platinum Sponsor of IAPP Asia Privacy Forum 2015 2Health News:AvePoint Showcases Compliance and Data Privacy Solutions as Platinum Sponsor of IAPP Asia Privacy Forum 2015 3Health News:AvePoint Showcases Compliance and Data Privacy Solutions as Platinum Sponsor of IAPP Asia Privacy Forum 2015 4Health News:SF-based Global Health Non-Profit Awards Harris Wofford Global Service Fellowship 2Health News:SF-based Global Health Non-Profit Awards Harris Wofford Global Service Fellowship 3
... Nov. 19 Smart Balance, Inc. (Nasdaq: SMBL ) ... to drive growth and performance at the Citi Investment Research ... strategy to build market share in the company,s core spreads ... of food and beverages to support healthy living under the ...
... JACKSONVILLE, Fla., Nov. 19 Improving the quality of ... will be addressed by Dr. Krysti DeZonia, co-founder of ... of the International Association for Life Quality (IALQ), at ... Fl. , The WCD Expo is dedicated ...
... Hopkins and their colleagues have developed sugar-coated polymer strands ... allergy and asthma attacks. Their advance is a significant ... conditions in a new way. For more than ... M.D., director of the Division of Allergy and Clinical ...
... Heart disease, stroke more likely for organ recipients with ... (HealthDay News) -- Kidney transplant patients with sleep apnea ... disease and stroke, Hungarian researchers say. , The study ... had moderate to severe sleep apnea, a rate similar ...
... analysis finds some areas with 1 in 10 adults ... While rates of obesity are climbing across America, they ... Southeast, the U.S. Centers for Disease Control and Prevention ... diabetes "are basically the two conditions of greatest concern ...
... Lisa Maas, executive director of Californians Allied for ... to an Associated Press/Stanford University poll released today which ... personal injury lawyers to sue health care providers. ... community clinics, local governments, dentists and other groups supporting ...
Cached Medicine News:Health News:Smart Balance, Inc. CEO Presents at Citigroup Small and Midcap Conference 2Health News:Smart Balance, Inc. CEO Presents at Citigroup Small and Midcap Conference 3Health News:Smart Balance, Inc. CEO Presents at Citigroup Small and Midcap Conference 4Health News:Dr. Krysti DeZonia to Speak at World Congress on Disabilities 2Health News:Sweet -- sugared polymer a new weapon against allergies and asthma 2Health News:Sweet -- sugared polymer a new weapon against allergies and asthma 3Health News:Kidney Transplant, Sleep Disorder May Add Up to Trouble 2Health News:Appalachia, Southeast Hit Hardest by Obesity and Diabetes 2Health News:Appalachia, Southeast Hit Hardest by Obesity and Diabetes 3Health News:National Poll Confirms Americans Support Curbs on Malpractice Lawsuits 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: